Compare BG & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BG | STE |
|---|---|---|
| Founded | 1818 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Packaged Foods | Industrial Specialties |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9B | 24.4B |
| IPO Year | 2023 | 2018 |
| Metric | BG | STE |
|---|---|---|
| Price | $121.94 | $251.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $125.29 | ★ $275.20 |
| AVG Volume (30 Days) | ★ 1.5M | 929.9K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.31% | 1.02% |
| EPS Growth | N/A | ★ 62.73 |
| EPS | 4.91 | ★ 5.69 |
| Revenue | ★ $70,329,000,000.00 | $5,459,515,000.00 |
| Revenue This Year | $34.76 | $9.84 |
| Revenue Next Year | $3.49 | $6.34 |
| P/E Ratio | ★ $24.72 | $44.22 |
| Revenue Growth | ★ 32.43 | 6.24 |
| 52 Week Low | $70.89 | $204.90 |
| 52 Week High | $124.78 | $269.44 |
| Indicator | BG | STE |
|---|---|---|
| Relative Strength Index (RSI) | 62.59 | 52.02 |
| Support Level | $74.58 | $249.57 |
| Resistance Level | $124.78 | $267.89 |
| Average True Range (ATR) | 3.38 | 5.54 |
| MACD | -0.69 | 0.58 |
| Stochastic Oscillator | 65.36 | 91.62 |
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes and corn-based products in North and South America.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.